Advancing Osteosarcoma Research to Protect Future Generations – Children’s Cancer Institute
Children’s Cancer Institute shared a post on LinkedIn:
“Sophie was just 14 when she was diagnosed with osteosarcoma – a rare, aggressive bone cancer that mostly affects children and young people.
Over the next decade, she endured a shoulder replacement, long stretches of missed school, and relentless treatment. At 17, she was diagnosed with a secondary cancer – leukaemia – and later that same year, lymphoma. These devastating side effects aren’t uncommon for sarcoma survivors, who face a higher risk of other cancers due to intense treatment.
Sophie’s osteosarcoma later returned in her lungs and brain. She passed away in May last year at 24 – a fierce, funny, and compassionate soul whose strength inspired everyone around her.
Through it all, Sophie dreamed of a future where no child would have to endure what she did. Her family and friends are now working to bring that vision to life by supporting vital osteosarcoma research at Children’s Cancer Institute.
With support from Cooper Rice-Brading Foundation, one of our wonderful partners, they’ve raised over $70,000 for life-saving osteosarcoma research, so that one day no child or young person will have to go through what Sophie did.
Visit the link to support Sophie’s mission.”
Video attached to the post.
More posts featuring Children’s Cancer Institute on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023